Overview
This volume provides a state-of-the-art review of the key aspects of HBV. It covers our current understanding of the HBV genome and lifecycle, liver-enriched factors in the regulation of HBV transcription and translation, HBV protein structures and biological functions, and the immunology and pathogenesis of HBV. It also provides an update on cell and animal models, as well as molecular approaches. The respective chapters also cover the clinical management of hepatitis B and discuss future research directions, in particular, the identification of molecular targets for pharmacological intervention. Given its scope, the book offers a valuable resource for students, researchers, clinicians, and health practitioners in the fields of virology, infectious disease, public health etc. Dr Hong Tang is a Professor and Director of the Center of Infectious Diseases, West China Hospital of Sichuan University.
Full Product Details
Author: Hong Tang
Publisher: Springer Verlag, Singapore
Imprint: Springer Verlag, Singapore
Edition: 1st ed. 2020
Volume: 1179
Weight: 0.454kg
ISBN: 9789811391538
ISBN 10: 981139153
Pages: 186
Publication Date: 27 November 2020
Audience:
Professional and scholarly
,
Professional & Vocational
Format: Paperback
Publisher's Status: Active
Availability: Manufactured on demand
We will order this item for you from a manufactured on demand supplier.
Reviews
The authors target medical students, researchers, and experienced clinicians. The book would capture the interest of those interested purely in the basic science aspects. (Cezarina Mindru, Doody's Book Reviews, April 3, 2020)
"""The authors target medical students, researchers, and experienced clinicians. The book would capture the interest of those interested purely in the basic science aspects."" (Cezarina Mindru, Doody's Book Reviews, April 3, 2020)"
Author Information
Dr Hong Tang, recipient of the China National Natural Science Foundation Award for Distinguished Young Scholars, is a Clinical Professor and Director of the Center of Infectious Diseases, State Key Laboratory of Biotherapy, West China Hospital of Sichuan University. Dr Tang received her MD and PhD from West China University of Medical Sciences, and subsequently completed a postdoctoral fellowship at the Department of Cell Biology, Scripps Research Institute, USA; and a further fellowship at the Department of Molecular Biology, Cancer Research Institute, Kanazawa University, Japan. She currently serves as vice chairperson of the Chinese Society of Infectious Diseases; vice chairperson of the Chinese Physician Association for Infectious Diseases; and chairperson of the Hepatology Society, Sichuan Medical Association (SMA). As a principal investigator, she has received more than 20 Chinese National grants in the field of infectious diseases focusing on the molecular biology, pathogenic mechanism and clinical management of HBV and HCV infections; she has also been responsible for more than 40 multicentre clinical trials studying the efficacy and safety of anti-HBV and anti-HCV drugs. She has published more than 100 articles and reviews (mainly in the field of viral hepatitis) in international journals including Hepatology, Proc Natl Acad Sci USA and J Virol.
